Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Enhancing Innate Anti-Viral Resistance Through A Community-Based Intervention - Generation Xchange

NCT05534425 is registered in ClinicalTrials.gov with University of California, Los Angeles as lead sponsor.

NCT NCT05534425
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05534425 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Enhancing Innate Anti-Viral Resistance Through A Community-Based Intervention - Generation Xchange
Lead sponsor
University of California, Los Angeles
Phase
Not applicable
Overall status
Enrolling by invitation
Start date
September 26, 2022
Completion date
August 31, 2027
Enrollment
160 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

virus infection, rna